Market Overview

Tobacco's Big Week

Share:
Tobacco's Big Week
Related MO
Bernstein Initiates On Tobacco Stocks: Philip Morris 'Leads The Way In The New Nicotine World'
Benzinga's Top Upgrades, Downgrades For October 16, 2018
Aphria: A Quarter Filled With Operational Challenges (Seeking Alpha)
Related BTI
Bernstein Initiates On Tobacco Stocks: Philip Morris 'Leads The Way In The New Nicotine World'
The Duel Over The JUUL: FDA Zeroes In On E-Cigarette Industry, Teen Use Concerns
Economic Data, Earnings Give U.S. Futures A Bump (Wall Street Breakfast Podcast) (Seeking Alpha)

The U.S. Food and Drug Administration is holding its Center for Tobacco Products meeting this week, and it could be a very important week for tobacco investors.

Height Securities analyst Stefanie Miller said Wednesday this week could mark the first steps in a decade-long transition in the tobacco industry.

“We think initial FDA actions on allowable nicotine levels in combustible cigarettes and other tobacco products will likely come at some point during 1Q2018 after yesterday's report by the National Academies provided Members of Congress concerned with the public health risks of tobacco products additional ammunition to force the FDA to release its long-awaited advanced notice of proposed rulemaking (ANPRM) on nicotine,” Miller said in a note.

She says Philip Morris International Inc. (NYSE: PM) could be one of the early winners if the FDA ramps up regulations because of the company’s new line of IQOS products.

Jefferies’ Take

Jefferies analyst Owen Bennett on Jan. 19 upgraded Philip Morris and Altria Group Inc (NYSE: MO) from Hold to Buy and said the shift to reduced-risk products and the potential for M&A in the space should drive stock outperformance among tobacco companies in 2018.

“Industry-wide catalysts include US CT guidance (suggestions not yet fully priced in, especially at MO; also sector-wide considerations of increased investment), the ANPRM on nicotine in the US (some downside likely; buy on the dip), Canadian litigation (concerns overdone but causing anxiety, especially at BAT), and possible heated tobacco approval in the US (big upside potential for first to market),” Bennett said.

Ratings And Targets

Tobacco investors will be watching to see how the FDA chooses to act this week as the tobacco companies try to stay relevant in profitable in an increasingly regulated market.

Jefferies has the following price targets and ratings for major tobacco stocks:

  • Altria-Buy rating, $81 target.
  • British American Tobacco PLC (ADR) (NYSE: BTI)-Buy rating, $80 target.
  • Philip Morris-Buy rating, $124 target.

Related Links:

The First US-Listed Marijuana ETF Ignites Today

What Were Once Vices Are Now Dividends: A Sinful New ETF

Latest Ratings for MO

DateFirmActionFromTo
Oct 2018BernsteinInitiates Coverage OnMarket Perform
Sep 2018CitigroupMaintainsNeutralNeutral
Aug 2018JefferiesDowngradesBuyHold

View More Analyst Ratings for MO
View the Latest Analyst Ratings

Posted-In: Analyst Color News Health Care Price Target Politics FDA Top Stories Analyst Ratings Best of Benzinga

 

Related Articles (BTI + MO)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
NKEOppenheimerUpgrades0.0
SBEvercore ISI GroupUpgrades4.5
PTIRBC CapitalUpgrades0.0
GPSJP MorganDowngrades24.0
GIIIB. Riley FBRUpgrades47.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

How iPhone X Weakness Caused A Downgrade Of Sony

Stripe Jumps Off Bitcoin Bandwagon, Citing Fewer Payment Use Cases